535 filings
Page 3 of 27
CORRESP
1vxfh1z yi
23 Nov 22
Correspondence with SEC
12:00am
8-K
e0r3ezhmolblknbwf2x
22 Nov 22
Other Events
5:00pm
8-K
l6hc93b5oiva82m4hdo
15 Nov 22
OncoSec presents encouraging early data with TAVO™-EP combined with nivolumab (Opdivo®) in neoadjuvant melanoma
5:06pm
8-K
2mywgl5r16llx
14 Nov 22
Other Events
6:10am
CORRESP
5qjt2hh63x2ft
14 Nov 22
Correspondence with SEC
12:00am
8-K
dlmqx
8 Nov 22
OncoSec Announces Reverse Stock Split
1:15pm
UPLOAD
xvtqs
8 Nov 22
Letter from SEC
12:00am
8-K
l7ol2xzjbxfq9ylvkj3
17 Oct 22
Departure of Directors or Certain Officers
5:00pm
8-K
llo4s1f7 1z02pr8swzf
11 Oct 22
Departure of Directors or Certain Officers
8:00am
8-K
y9br y841oy
4 Oct 22
OncoSec Announces Pipeline Prioritization and Workforce Reduction
5:28pm
8-K
3nyd gf2kt
3 Oct 22
Departure of Directors or Certain Officers
5:00pm
S-8
lqm616jsg 08
29 Jul 22
Registration of securities for employees
4:29pm
8-K
mq8sr74
12 Jul 22
Submission of Matters to a Vote of Security Holders
5:21pm
8-K
4isk7ddarag vtb1ln7
9 Jun 22
Other Events
4:30pm
8-K
3qjcte 7y14pf
3 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
DEFA14A
ha49kmu1x d7tf
31 May 22
Additional proxy soliciting materials
4:30pm